Duc Binh Phan

6PUBLICATIONS
16CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infectious diseasesAutoimmunityRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 08, 2026
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods.

|Mar 16, 2026
Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Duc Binh Phan, Philip Laws, Catherine H Smith

|Oct 31, 2025
Serious Infection Risk with Systemic Treatments for Psoriasis: A Systematic Review and Network Meta-analysis Combining Randomised and Non-randomised Evidence.

Heber Rew Bright Bright, Duc Binh Phan, Amna Zahid

|Mar 03, 2025
Switching back to originator adalimumab from biosimilars in psoriasis: A cohort study from BADBIR.

Duc Binh Phan, Mark Lunt, Richard B Warren

|Jul 14, 2023
Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.

Duc Binh Phan, Hugo Jourdain, Alicia González-Quesada

|Apr 04, 2023
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR).

Duc Binh Phan, Anthony P Bewley, Catherine H Smith

Pageof 1

Frequent Collaborators

6 joint publications

Zenas Z N Yiu

3 joint publications

Richard B Warren

2 joint publications

Catherine H Smith

2 joint publications

Gabriel Rogers